GLS and glioblastoma: We have performed a differential expression analysis comparing SERPINA3 and key GAM markers between glioma samples and non-tumor tissues from the databases, which confirmed significant upregulation of SERPINA3 and GAM markers in both LGG and GBM tumors compared to normal tissues (Fig. S1).